AZTherapiesAZTherapies

Changing Neurodegenerative Disease Progression

  • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Business Advisors
  • Our Science
    • Alzheimer’s Disease
    • Post-Ischemic Stroke
    • ALS
    • CAR-Treg
    • Publications
  • Pipeline
  • News & Events
  • Careers
  • Contact

Monthly Archives: July 2020

AZTherapies   →  Homepage-1   →  2020   →  July

Categories

  • Events 2
  • News 1
  • Press Releases 18

Recent Posts

  • AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021November 18, 2020
  • AZTherapies Announces Leadership Transition, Appointing Marc de Garidel Chief Executive Officer and Member of the Board of DirectorsOctober 1, 2020
  • AZTherapies Announces Closing of $33.6 Million Series C-1 Financing Building Upon Recent $37.5 Million Series C FinancingSeptember 29, 2020
  • AZTherapies Doses First Patient in Phase 2a Study of ALZT-OP1a in Amyotrophic Lateral Sclerosis (ALS)September 9, 2020
  • AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory BoardAugust 11, 2020

Archives

  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • February 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019

Copyright ©2021 AZTherapies, Inc. All rights reserved

Site Map | Terms of Use/Privacy Policy | Web Design: Someone Creative